Laekna Therapeutics
Business Services · China · 51-200 Employees
View Company Info for Free
Overview
Headquarters
张江 蔡 987号 伦路 5楼, 201203, ChinaPhone Number
+86 2150716089Website
www.laekna.comRevenue
<$5 MillionIndustry
About Laekna Therapeutics
Laekna Therapeutics Org Chart
Is Laekna Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Laekna Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Laekna Therapeutics launches new products
Laekna Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Laekna Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Laekna Therapeutics
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Laekna Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Laekna Therapeutics is spiking on competitors!
Earning: See what the market has to say on Laekna Therapeutics recently announced quarterly report
Recommended Actions
Find VP level buyers at Laekna Therapeutics
Find 3 more new buyers
Company Profile Activity
Activity Insights
Laekna Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Laekna Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Laekna Therapeutics.
Laekna Therapeutics Tech Stack
Most Recent Scoops
Laekna Therapeutics News & Media
New Drug Application for LAE002 (afuresertib) Accepted by China's National Medical Products Administration
SHANGHAI, Aug. 11, 2026 /PRNewswire/ -- Laekna (2105.HK) announced today that the New Drug Application (NDA) for LAE002 (afuresertib) has been accepted by the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) for the treatment of patients with...Eyes on Asia: Insilico, Laekna, XtalPi - BioXconomy
BioXconomy presents the Asia biopharma and healthcare dealmaking highlights for the week ending June 21, 2026.
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Laekna Therapeutics
Laekna Therapeutics is an innovative biopharmaceutical company focused on developing breakthrough therapies for cancer and liver fibrosis patients worldwide. Established in 2016, the company operates with a research and development team based in both China and the United States. Laekna has a diverse pipeline of 19 innovative drug candidates, includ... Read More